All News about Akero Therapeutics Inc
Thanks To Encouraging Data, These Mid-Cap Stocks Layout $300M Equity Raise
September 14, 2022
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2023
January 27, 2023
Via Benzinga
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 19, 2022
Via Benzinga
Efruxifermin Granted FDA Breakthrough Therapy Designation for NASH
December 08, 2022
From Akero Therapeutics
Via GlobeNewswire
From Akero Therapeutics
Via GlobeNewswire
Stocks That Hit 52-Week Lows On Friday
November 25, 2022
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 14, 2022
September 14, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|